EMEA-002684-PIP01-19

Table of contents

Key facts

Active substance
mitapivat
Therapeutic area
Haematology-Hemostaseology
Decision number
P/0365/2020
PIP number
EMEA-002684-PIP01-19
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
Treatment of pyruvate kinase deficiency
Route(s) of administration
Oral use
Contact for public enquiries
Agios Pharmaceuticals, Inc.

Tel.  +1 8332288474
E-mail: medinfo@agios.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating